tiprankstipranks
Fangzhou Inc. (HK:6086)
:6086
Hong Kong Market

Fangzhou Inc. (6086) Price & Analysis

Compare
0 Followers

6086 Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

100.00%
Insiders
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors

6086 FAQ

What was Fangzhou Inc.’s price range in the past 12 months?
Fangzhou Inc. lowest stock price was HK$1.60 and its highest was HK$8.18 in the past 12 months.
    What is Fangzhou Inc.’s market cap?
    Currently, no data Available
    When is Fangzhou Inc.’s upcoming earnings report date?
    Fangzhou Inc.’s upcoming earnings report date is Mar 21, 2025 which is 8 days ago.
      How were Fangzhou Inc.’s earnings last quarter?
      Fangzhou Inc. released its earnings results on Aug 28, 2024. The company reported -HK$0.668 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.668.
        Is Fangzhou Inc. overvalued?
        According to Wall Street analysts Fangzhou Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Fangzhou Inc. pay dividends?
          Fangzhou Inc. does not currently pay dividends.
          What is Fangzhou Inc.’s EPS estimate?
          Fangzhou Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Fangzhou Inc. have?
          Fangzhou Inc. has 1,340,267,500 shares outstanding.
            What happened to Fangzhou Inc.’s price movement after its last earnings report?
            Fangzhou Inc. reported an EPS of -HK$0.668 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.483%.
              Which hedge fund is a major shareholder of Fangzhou Inc.?
              Currently, no hedge funds are holding shares in HK:6086
              ---

              Company Description

              Fangzhou Inc.

              Fangzhou Inc. provides online chronic disease management services in China. The company provides services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It offers H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; and healthcare products through online retail pharmacy service platform, as well as operates hospitals and offline pharmacies. The company was founded in 2015 and is based in Guangzhou, China.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Meituan Dianping
              Sunny Optical Technology (Group) Co
              Xiaomi
              Baidu, Inc. Class A
              Netease Inc
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis